
Beyond testis cancer: Koch led IU urology to national prominence with expanded faculty expertise
During his 26 years as urology chair at IU School of Medicine, Michael Koch, MD, quadrupled the department's faculty, adding expertise and making IU's urology program one the largest and most impactful in the U.S.

Adra’s impact: IU genitourinary oncologist named to IBJ ‘Forty Under 40’
Nabil Adra, MD, was named to the IBJ 2024 Forty Under 40 for his work in genitourinary cancer treatment and research. He aims to carry

IU School of Medicine enrolls 100th patient in 23-site brain tumor radiation therapy clinical trial
Indiana University School of Medicine is one of 23 institutions in the Radiation One and Done Study (ROADS) clinical trial, and the university, in conjunction with

Urologic oncologist turns to IU mentors for his own testicular cancer treatment
Sean Kern, MD, an IU-trained urologic oncologist and founding director of the military’s testicular cancer enterprise, was diagnosed with the very disease he specializes in

From lab to market: Discoveries in Kelley Lab lead to new therapies for multiple diseases
Over the last 30 years, Mark R. Kelley has disclosed 61 inventions, been awarded 19 patents and launched a pharmaceutical startup. Now he's helping other

Duncan leads quest to end health disparities in lung cancer
Francesca Duncan, MD, is determined to end disparities in the diagnosis and treatment of lung cancer—the leading cause of cancer deaths in the United States.

Mutations, mammograms and MRIs, oh my! How I took charge of my breast health with increased screenings, and when you should do the same
Christina Griffiths is a media relations specialist for Indiana University School of Medicine and has worked with the office of strategic communications for five years.

Doyle Publishes in Health Affairs on Personal Experience with Decision Aids
Tom Doyle, PhD, a postdoctoral fellow from the Center for Bioethics, reflects on his recent publication in Health Affairs on his personal experience with Hodgkin's

IU researchers find link between obesity and blood cancer
Indiana University School of Medicine researchers found a strong association between obesity and clonal hematopoiesis of indeterminate potential (CHIP), a condition where blood cells accumulate

Researchers uncover new drug combination to treat rare pediatric cancer called JMML
IU School of Medicine researchers have identified a promising new combination of drugs for treating a rare form of childhood blood cancer called JMML.